Korys

Korys is a Belgium-based family office established in 2000 by the Colruyt family, named after the Latin word for hazelnut tree, which connects to their family heritage. The firm employs a multi-disciplinary investment strategy, focusing on a diversified portfolio that includes listed stocks, bonds, private equity funds, and direct investments in small and medium-sized enterprises. Korys emphasizes a long-term investment approach aimed at generating attractive returns while fostering a positive impact on society and the environment, guided by their "three P" philosophy: People, Planet, and Profit. The firm's expertise spans several sectors, particularly Cleantech, consumer goods and retail, and life sciences, allowing them to invest effectively in companies at various stages, from seed funding to expansion.

Frederik Bauwens

Investment Director

Karel Van Cleemput

Investment Manager

Dries Colpaert

Senior Advisor

Dries Crevits

Partner

Bart Elst

Investment Director

Sofie Gabriëls

Chief Financial Officer and Director of Administration

Guillaume Hollanders

Chief Financial Officer

Brieuc de Hults

Investment Director

Thomas De Kempeneer

Senior Investment Manager

Joost Van Laer

Investment Manager

Daniel Leuthardt

Investment Director

Katti Van Oosterwijck

Investment Manager

Pablo Queriat

Senior Investment Manager

Raf Roelands

Investment Manager

Gert Ryckmans

Senior Investment Manager

Loïc de Schaetzen

Investment Director

Vincent De Smet

Investment Manager

Richard Stadler

Investment Manager

Jérôme Thomas

Investment Director

Vincent Vliebergh

Managing Partner

Past deals in Belgium

reMYND

Series B in 2021
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models. They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugs currently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept.

Ampacimon

Venture Round in 2020
Ampacimon develops dynamic line rating systems for transmission and distribution systems operators. Ampacimon’s products address grid infrastructure challenges such as aging assets, transmissions congestion, renewable integration, interconnectors.

Urbantz

Series A in 2020
Urbantz is a delivery management platform to optimize and control first and last mile operations, from the initial order to the final recipient. The award-winning SaaS solution enables retailers, e-commerce players and carriers to provide recipients an outstanding delivery experience.

Sitemark

Series A in 2019
Sitemark develops a platform and application that help its users improve operational efficiency through high quality aerial data. The platform provides services, such as precise measurements of distance, area, volume, gradient, and temperature. The application developed by the company helps users plan automated flight paths. The company caters to industries, such as solar, construction, and mining and aggregates. The company was founded in 2016 and is headquartered in Leuven, Belgium.

reMYND

Venture Round in 2018
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models. They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugs currently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept.

ONTOFORCE

Series A in 2018
ONTOFORCE N.V., founded in 2011 and based in Gent, Belgium, specializes in semantic search technology for effective information management. The company offers disQover, a search engine that intelligently links various autonomous data sources, enabling users to connect internal and private data with external and public information. Additionally, ONTOFORCE provides schoolKID, a platform designed to manage and share student information across educational institutions, as well as consultancy services to support its clients in optimizing their data usage.

ProDigest

Venture Round in 2017
ProDigest provides customized solutions related to gastrointestinal research to the operators in the market of food/feed, functional food/feed and pharmaceutical industry. Our expertise in the field of gastrointestinal transit, bioavailability and metabolism of food/feed compounds and pharmaceuticals, in relation to their fate and function in the body, makes ProDigest an essential partner for innovative product development.

Smartmat

Venture Round in 2016
Smartmat N.V. provides food delivery services in the form of dinner boxes. The company focuses on local and biological ingredients. The company was founded in 2012 and is based in Antwerp, Belgium.

Genae

Venture Round in 2016
genae is the leading medical device Contract Research Organization (CRO) that accelerates innovation through collaborative insights & global expertise with results that matter. Dedicated to Medical Devices, delivering what is promised.

Parkwind

Seed Round in 2013
Parkwind NV develops, finances, builds, and operates wind farms in the North Sea. Parkwind NV has a strategic partnership with Sumitomo Corporation.

Planet-eco

Venture Round in 2010
Planet-eco NV, founded in 2008 and based in Ninove, Belgium, specializes in the retail and installation of sustainable energy technologies. The company offers a range of products including solar panels, solar water heaters, gas condensing boilers, heat pumps, underfloor heating systems, ventilation systems, and water softeners. Planet-eco focuses on analyzing clients' energy consumption to provide customized solutions that address technical, financial, and subsidy-related aspects of energy efficiency. Their aim is to promote the adoption of renewable energy technologies while ensuring tailored, effective installations for their customers.